DUBLIN, Ireland — Allergan plc is set to release Rhofade oxymetazoline hydrochloride cream 1%, a topical medication to help treat rosacea. Indicated for persistent facial erythema, or redness, associated with rosacea in adults, Rhofade adds brings a once-daily solution to the few alternatives available for the treatment of this rosacea symptom, Allergan said. Plans call
DUBLIN, Ireland — Allergan plc plans to buy clinical-stage biotech firm Vitae Pharmaceuticals Inc. in a cash deal valued at $639 million. Allergan said the acquisition will bolster its dermatology product pipeline with the addition of VTP-43742, a Phase 2 orally active RORγt inhibitor for the potential treatment of psoriasis and other autoimmune disorders. The
DUBLIN, Ireland — Allergan plc has teamed up with actress and model Kate Bosworth to launch Aczone Gel 7.5%, a new prescription topical treatment for acne. Also on Monday, Allergan said it has received Food and Drug Administration approval for Byvalson tablets (nebivolol 5 mg/valsartan 80 mg), a hypertension treatment that the company called the
